NEW YORK (GenomeWeb News) – Mayo Clinic is partnering with three US healthcare groups to study if prescribing heart medications based on a patient's genotype will improve outcomes in angioplasty patients, NorthShore University HealthSystem, one of the project partners, said today.

The Tailored Antiplatelet Therapy to Lessen Outcomes After Percutaneous Coronary Intervention (TAILOR-PCI) study seeks to find out if testing for a patient's genotype will help prevent heart attack, stroke, unstable angina, and cardiovascular death in patients who undergo angioplasty.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.